Other Assets, Current of NEKTAR THERAPEUTICS from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
NEKTAR THERAPEUTICS quarterly Other Assets, Current in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NEKTAR THERAPEUTICS Other Assets, Current for the quarter ending 30 Sep 2025 was $11,149,000, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

NEKTAR THERAPEUTICS Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,149,000 +$2,216,000 +25% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $10,663,000 +$2,371,000 +29% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $11,281,000 +$538,000 +5% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $6,066,000 -$3,713,000 -38% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $8,933,000 -$100,000 -1.1% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $8,292,000 -$1,310,000 -14% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $10,743,000 -$266,000 -2.4% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $9,779,000 -$6,029,000 -38% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $9,033,000 -$13,474,000 -60% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $9,602,000 -$9,643,000 -50% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $11,009,000 -$9,822,000 -47% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $15,808,000 -$7,525,000 -32% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $22,507,000 +$1,776,000 +8.6% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $19,245,000 +$6,649,000 +53% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $20,831,000 +$5,060,000 +32% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $23,333,000 +$1,405,000 +6.4% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $20,731,000 -$819,000 -3.8% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $12,596,000 -$25,174,000 -67% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $15,771,000 +$1,960,000 +14% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $21,928,000 +$6,541,000 +43% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $21,550,000 +$6,338,000 +42% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $37,770,000 +$24,557,000 +186% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $13,811,000 -$5,541,000 -29% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $15,387,000 -$5,906,000 -28% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $15,212,000 +$2,672,000 +21% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $13,213,000 -$21,727,000 -62% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $19,352,000 +$6,278,000 +48% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $21,293,000 +$13,500,000 +173% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 $12,540,000 -$720,000 -5.4% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $34,940,000 +$27,444,000 +366% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $13,074,000 +$5,193,000 +66% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $7,793,000 -$2,270,000 -23% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 $13,260,000 +$9,252,000 +231% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $7,496,000 +$2,069,000 +38% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $7,881,000 +$2,288,000 +41% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $10,063,000 +$249,000 +2.5% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $4,008,000 -$1,206,000 -23% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 $5,427,000 -$3,355,000 -38% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $5,593,000 -$499,000 -8.2% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 $9,814,000 +$997,000 +11% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $5,214,000 +$506,000 +11% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 $8,782,000 +$4,153,000 +90% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $6,092,000 +$120,000 +2% 31 Mar 2015 10-Q 01 May 2015 2015 Q1
Q4 2014 $8,817,000 +$3,642,000 +70% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $4,708,000 -$51,000 -1.1% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $4,629,000 -$1,389,000 -23% 30 Jun 2014 10-Q 01 Aug 2014 2014 Q2
Q1 2014 $5,972,000 -$2,841,000 -32% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $5,175,000 -$8,188,000 -61% 31 Dec 2013 10-K 26 Feb 2015 2014 FY
Q3 2013 $4,759,000 -$2,244,000 -32% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $6,018,000 -$3,323,000 -36% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 $8,813,000 -$4,821,000 -35% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $13,363,000 -$4,581,000 -26% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q3 2012 $7,003,000 -$562,000 -7.4% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $9,341,000 +$1,409,000 +18% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $13,634,000 +$6,775,000 +99% 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 $17,944,000 +$12,265,000 +216% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 $7,565,000 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 $7,932,000 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q1 2011 $6,859,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 $5,679,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.